{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:39:38Z","timestamp":1790872778534,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073890"],"award-info":[{"award-number":["82073890"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bcp.2025.116796","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T19:46:55Z","timestamp":1738957615000},"page":"116796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis"],"prefix":"10.1016","volume":"233","author":[{"given":"Qingxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bcp.2025.116796_b0005","first-page":"2035","article-title":"Dabrafenib and trametinib, alone and in combination for BRAF-mutant metastatic melanoma, Clinical cancer research : an official journal of the American Association for","volume":"20","author":"Menzies","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.116796_b0010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1634\/theoncologist.2017-0642","article-title":"FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations","volume":"23","author":"Odogwu","year":"2018","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.bcp.2025.116796_b0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.bcp.2025.116796_b0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ctrv.2018.04.006","article-title":"BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall","volume":"66","author":"Leonetti","year":"2018","journal-title":"Cancer Treat. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2025.116796_b0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations innon-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40169-015-0074-1","article-title":"Clinical potential of gene mutations in lung cancer","volume":"4","author":"Carper","year":"2015","journal-title":"Clin. Transl. Med."},{"issue":"21","key":"10.1016\/j.bcp.2025.116796_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215430","article-title":"KRAS in NSCLC: State of the Art and Future Perspectives","volume":"14","author":"Cascetta","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0040","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","article-title":"KRAS mutation: from undruggable to druggable in cancer","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bcp.2025.116796_b0045","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","article-title":"Targeting the MAPK Pathway in KRAS-Driven Tumors","volume":"37","author":"Drosten","year":"2020","journal-title":"Cancer Cell"},{"issue":"13","key":"10.1016\/j.bcp.2025.116796_b0050","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.7150\/thno.71260","article-title":"Conquering oncogenic KRAS and its bypass mechanisms","volume":"12","author":"Hou","year":"2022","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.bcp.2025.116796_b0055","first-page":"1482","article-title":"FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC, Clinical cancer research : an official journal of the American Association for","volume":"28","author":"Nakajima","year":"2022","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.116796_b0060","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tem.2019.03.003","article-title":"Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells","volume":"30","author":"Bernfeld","year":"2019","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2025.116796_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104844","article-title":"Target the human Alanine\/Serine\/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy","volume":"158","author":"Jiang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"3168","key":"10.1016\/j.bcp.2025.116796_b0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1126\/science.122.3168.501","article-title":"Nutrition needs of mammalian cells in tissue culture","volume":"122","author":"Eagle","year":"1955","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bcp.2025.116796_b0075","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100920","article-title":"Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC","volume":"14","author":"Xia","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bcp.2025.116796_b0085","article-title":"Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116796_b0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.902305","article-title":"Anticancer Effects of Amlodipine Alone or in Combination With Gefitinib in Non-Small Cell Lung Cancer","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/imr.12287","article-title":"Pyroptotic cell death defends against intracellular pathogens","volume":"265","author":"Jorgensen","year":"2015","journal-title":"Immunol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0100","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0105","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/s41467-019-09397-2","article-title":"Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation","volume":"10","author":"Rogers","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-018-0856-3","article-title":"Critical role of FOXO3a in carcinogenesis","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2025.116796_b0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncb1676","article-title":"ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation","volume":"10","author":"Yang","year":"2008","journal-title":"Nat. Cell Biol."},{"issue":"7","key":"10.1016\/j.bcp.2025.116796_b0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5732\/cjc.012.10277","article-title":"Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance","volume":"32","author":"Gomes","year":"2013","journal-title":"Chin. J. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2017.178","article-title":"Targeting Glutamine Metabolism for Cancer Treatment","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2025.116796_b0130","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2005.10.056","article-title":"JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species","volume":"40","author":"Shen","year":"2006","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2025.116796_b0135","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jcp.22839","article-title":"A pathway from JNK through decreased ERK and Akt activities for FOXO3a nuclear translocation in response to UV irradiation","volume":"227","author":"Wang","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2025.116796_b0140","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semcancer.2017.11.018","article-title":"The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance","volume":"50","author":"Yao","year":"2018","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.116796_b0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1389450115666141122211549","article-title":"Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance","volume":"17","author":"Nestal de Moraes","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bcp.2025.116796_b0150","article-title":"FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis","volume":"10","author":"Kalathil","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2025.116796_b0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.semcancer.2021.05.010","article-title":"RAF-MEK-ERK pathway in cancer evolution and treatment","volume":"85","author":"Ullah","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0160","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/14728222.2011.645805","article-title":"Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy","volume":"16","author":"Santarpia","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"issue":"9","key":"10.1016\/j.bcp.2025.116796_b0165","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.tcb.2017.05.005","article-title":"Gasdermins: Effectors of Pyroptosis","volume":"27","author":"Kovacs","year":"2017","journal-title":"Trends Cell Biol."},{"issue":"13","key":"10.1016\/j.bcp.2025.116796_b0170","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1016\/j.cub.2016.02.019","volume":"26","author":"Vande Walle","year":"2016","journal-title":"Pyroptosis. Curr. Biol."},{"key":"10.1016\/j.bcp.2025.116796_b0175","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"issue":"7661","key":"10.1016\/j.bcp.2025.116796_b0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bcp.2025.116796_b0185","first-page":"1089","article-title":"Metformin activates AMPK\/SIRT1\/NF-\u03baB pathway and induces mitochondrial dysfunction to drive caspase3\/GSDME-mediated cancer cell pyroptosis, Cell cycle","volume":"19","author":"Zheng","year":"2020"},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.116796_b0190","first-page":"312","volume":"24","author":"Zhang","year":"2019","journal-title":"Chemotherapeutic Paclitaxel and Cisplatin Differentially Induce Pyroptosis in A549 Lung Cancer Cells via Caspase-3\/GSDME Activation. Apoptosis"},{"key":"10.1016\/j.bcp.2025.116796_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107943","article-title":"The interplay between apoptosis and cellular senescence: Bcl-2 family proteins as targets for cancer therapy","volume":"230","author":"Basu","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2025.116796_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061292","article-title":"Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives","volume":"13","author":"Hafezi","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bcp.2025.116796_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"10","key":"10.1016\/j.bcp.2025.116796_b0210","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.168.10.5024","article-title":"The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2","volume":"168","author":"Stahl","year":"2002","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.bcp.2025.116796_b0215","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1","volume":"10","author":"Dijkers","year":"2000","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2025.116796_b0220","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00018-015-2112-y","article-title":"FOXO transcription factors in cancer development and therapy","volume":"73","author":"Coomans de Brach\u00e8ne","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"14","key":"10.1016\/j.bcp.2025.116796_b0225","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.1074\/jbc.M213069200","article-title":"Akt activation promotes degradation of tuberin and FOXO3a via the proteasome","volume":"278","author":"Plas","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.116796_b0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1083\/jcb.200409117","article-title":"JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3","volume":"170","author":"Sunayama","year":"2005","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1158\/0008-5472.CAN-05-1997","article-title":"Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt","volume":"66","author":"Sunters","year":"2006","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bcp.2025.116796_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/cells8091110","article-title":"FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response","volume":"8","author":"Fasano","year":"2019","journal-title":"Cells"},{"issue":"41","key":"10.1016\/j.bcp.2025.116796_b0245","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2025.116796_b0250","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma","volume":"79","author":"Galan-Cobo","year":"2019","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.bcp.2025.116796_b0255","first-page":"2949","article-title":"Cell-Cycle Therapeutics Come of Age, Journal of clinical oncology : official journal of the American Society of","volume":"35","author":"Ingham","year":"2017","journal-title":"Clin. Oncol."},{"issue":"17","key":"10.1016\/j.bcp.2025.116796_b0260","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/0008-5472.CAN-19-3663","article-title":"p27 as a Transcriptional Regulator: New Roles in Development and Cancer","volume":"80","author":"Razavipour","year":"2020","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.116796_b0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","article-title":"FoxOs at the crossroads of cellular metabolism, differentiation, and transformation","volume":"117","author":"Accili","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1074\/jbc.M705792200","article-title":"FoxM1 regulates growth factor-induced expression of kinase-interacting stathmin (KIS) to promote cell cycle progression","volume":"283","author":"Petrovic","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2025.116796_b0275","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1073\/pnas.201360898","article-title":"Increased levels of forkhead box M1B transcription factor in transgenic mouse hepatocytes prevent age-related proliferation defects in regenerating liver","volume":"98","author":"Wang","year":"2001","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.bcp.2025.116796_b0280","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","article-title":"Glutamine reliance in cell metabolism","volume":"52","author":"Yoo","year":"2020","journal-title":"Exp. Mol. Med."},{"issue":"8","key":"10.1016\/j.bcp.2025.116796_b0285","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00204-020-02838-8","article-title":"Glutaminases regulate glutathione and oxidative stress in cancer","volume":"94","author":"Mat\u00e9s","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bcp.2025.116796_b0290","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2019.04.039","article-title":"Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism","volume":"227","author":"Thirupathi","year":"2019","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0295","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI73941","article-title":"The role for autophagy in cancer","volume":"125","author":"White","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.bcp.2025.116796_b0300","first-page":"5037","article-title":"Autophagy, Metabolism, and Cancer, Clinical cancer research : an official journal of the American Association for","volume":"21","author":"White","year":"2015","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.bcp.2025.116796_b0305","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.116796_b0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s11658-016-0031-z","article-title":"p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation","volume":"21","author":"Liu","year":"2016","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"33","key":"10.1016\/j.bcp.2025.116796_b0315","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","article-title":"p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy","volume":"282","author":"Pankiv","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.116796_b0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-1138-4","article-title":"Autophagy and autophagy-related proteins in cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:13:55Z","timestamp":1745842435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":64,"alternative-id":["S0006295225000589"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116796","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamine transporter inhibitor enhances the sensitivity of NSCLC to trametinib through GSDME-dependent pyroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116796"}}